← back to search

Hang Wang

Tongji University · CN
Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include Extracellular vesicles in disease, MicroRNA in disease regulation, Circular RNAs in diseases, and RNA modifications and cancer.
h-index
14
citations
1,098
works
47
NIH funding
primary concept
email

Recent publications

TFAP2A-regulated CRNDE enhances colon cancer progression and chemoresistance via RIPK3 interaction
Functional & Integrative Genomics 2025cited by 3position: middledoi
Development and validation of a deep learning-based pathomics signature for prognosis and chemotherapy benefits in colorectal cancer: a retrospective multicenter cohort study
Frontiers in Immunology 2025cited by 2position: middledoi
Development and validation of a deep learning–based pathomics signature for prognosis and chemotherapy benefits in colorectal cancer: A retrospective multicenter cohort study.
Journal of Clinical Oncology 2025cited by 1position: middledoi
The adverse effects of developmental exposure to polystyrene nanoparticles on cognitive function in weaning rats and the protective role of trihydroxy phenolacetone
Environmental Pollution 2024cited by 7position: firstdoi
Roles and Molecular Mechanisms of Biomarkers in Hepatocellular Carcinoma with Microvascular Invasion: A Review
Journal of Clinical and Translational Hepatology 2023cited by 19position: middledoi
Extracellular Vesicles Act as Carriers for Cargo Delivery and Regulate Wnt Signaling in the Hepatocellular Carcinoma Tumor Microenvironment
Cancers 2023cited by 6position: middledoi
Prognostic factors in patients with first diagnosis of hepatocellular carcinoma presenting with pulmonary metastasis and construction of a clinical prediction model
Updates in Surgery 2023cited by 4position: firstdoi
Tumor-associated Exosomes Are Involved in Hepatocellular Carcinoma Tumorigenesis, Diagnosis, and Treatment
Journal of Clinical and Translational Hepatology 2022cited by 14position: firstdoi
Transcriptional ITPR3 as potential targets and biomarkers for human pancreatic cancer
Aging 2022cited by 9position: middledoi
G Protein Subunit Gamma 5 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Hepatocellular Carcinoma
Disease Markers 2022cited by 8position: firstdoi
RPNs Levels Are Prognostic and Diagnostic Markers for Hepatocellular Carcinoma
Journal of Oncology 2022cited by 8position: middledoi
Exosomal Noncoding RNAs in Hepatobiliary Cancer: A Rising Star
Molecular Cancer Therapeutics 2021cited by 4position: middledoi
RPNs Levels are Prognostic and Diagnostic Markers for Hepatocellular Carcinoma
Research Square 2021cited by 1position: middledoi
Identification of Potent and Selective Diphenylpropanamide RORγ Inhibitors
ACS Medicinal Chemistry Letters 2012cited by 64position: middledoi
Inhibitory Effects of Robo2 on Nephrin: A Crosstalk between Positive and Negative Signals Regulating Podocyte Structure
Cell Reports 2012cited by 63position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Nanfeng Meng · Harbin Medical University8 papers (2021–2023)Yi Xu · Central South University7 papers (2021–2023)Yunfu Cui · Harbin Medical University7 papers (2021–2023)Liang Yu · China National Offshore Oil Corporation (China)6 papers (2021–2023)Yongxu Zhou · Kookmin University5 papers (2021–2022)Judy Wai Ping Yam · Southern Medical University5 papers (2021–2023)Wangyang Zheng · Third Affiliated Hospital of Harbin Medical University5 papers (2021–2022)Ziyue Huang · Guangzhou University of Chinese Medicine4 papers (2021–2022)Yuling Zheng · Harbin Medical University4 papers (2021–2022)Daolin Ji · Harbin Engineering University4 papers (2021–2022)Shenghan Lou · Harbin Medical University3 papers (2025–2025)Risheng He · Harbin Medical University3 papers (2022–2023)Gary Mo · Eli Lilly (United States)3 papers (2025–2025)Huiying Li · Harbin Medical University2 papers (2025–2025)Peng Han · Chinese PLA General Hospital2 papers (2025–2025)Peng Huang · Nanchang University2 papers (2021–2022)Yunfu Cui · Harbin Medical University2 papers (2021–2023)Wenjie Song · Harbin Medical University2 papers (2025–2025)Haonan Xie · Harbin Medical University2 papers (2025–2025)Xue Bai · Dalian Medical University2 papers (2021–2021)